TGFB1 and systemic sclerosis: Based on the statistical analyses, miR-27a could serve as a reliable diagnostic marker for SSc, and given its proposed role in regulating TGF-β and other contributing pathways to SSc, it could be considered as a treatment option both for SSc and its related disorders and complications, which indeed necessitates further investigations.